Immunosurveillance has been demonstrated in the Vk∗MYC mouse model, where immune control of MM was demonstrated via NK and CD8+ T cells through CD226 (DNAM-1) interaction with its ligand CD155 on malignant plasma cells [23]. Here, CD226 is linked to Miyoshi myopathy.